COVID-19 Coronavirus and Influenza A/B Virus RT-PCR Kit

This site is a B2B information site for professional use - clinical diagnostics products listed are for Research Use Only unless otherwise stated.

Copan CoScience HUB the source of microbiology excellence

rapidmicrobiology expert insights interview with Sartorius water quality expert Dr Nils Jager

Merck Expert Insights on Filling the Traceability and Data Integrity Gap in Sterility Testing

rapidmicrobiology special focus on Chapter 86 updated and sustainable endotoxin testing

Go back to product finder page

COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit

Clinical & Veterinary

Principle: Fluorescence real-time quantitative PCR

Automation: Yes

Approvals: CE-IVD

Suitability: Bioperfectus Technologies Influenza A And B Viruses Real Time PCR Kit is an in vitro diagnostic test, based on real-time PCR technology, for the detection of Influenza A and B Viruses RNA.

Capital equipment required: Real-time PCR thermal cycler: Applied Biosystems 7500, QuantStudio™ 5, Roche LightCycler®480, Bio-Rad CFX96™, Shanghai Hongshi SLAN-96P/S, Suzhou Molarry MA-6000

Description:

COVID-19 Coronavirus and Influenza A/B virus Real-Time PCR Kit are an In Vitro Diagnostic (IVD) reagent relying on fluorescent PCR technology for the qualitatively detection and differentiation of RNA from SARS-CoV-2, influenza A virus, and/or influenza B virus from upper and lower respiratory tract samples. Upper and lower respiratory tract samples include throat swab and sputum.

Key Points:

Target region: Influenza A and Influenza B specific RNA
Clinical Sensitivity: 96.1% (Flu A) 97.5% (Flu B)
Clinical Specificity: 98.7% (Flu A) 98.2% (Flu B)
Limit of detection: 2.0 TCID₅₀/mL
Sample input volume: 5μL
Sample type: RNA in clinical specimens, including throat swab, nasal and pharyngeal secretions and cell culture supernatant